An Exploratory Clinical Study of LDP Combined With CDP1 in Patients With Advanced Malignant Tumor
Status:
Recruiting
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
This is an exploratory clinical study of Human Anti-PD-L1 Monoclonal Antibody Injection (LDP)
combined with Recombinant Anti-EGFR Human Mouse Chimeric Monoclonal Antibody Injection (CDP1)
in patients with advanced malignant tumor.